+91-33-4600-9199  (India), +1-414-240-5010 (U.S.)
Life Science Analytics Market is expected to witness 19.6% CAGR between 2021-2031- Market Insights, Size, Share, Growth, Trends, Analysis, and Forecast
Published : June 2021

According to a new market research report published by sheer analytics and insights, “The Global Life Science Analytics Market was valued at $14.3 Billion in 2020. The market is growing at a high CAGR of more than 19.6% between 2021 and 2031, and it is estimated to reach $104.3 Billion by 2031, as per the latest market research report titled Global Life Science Analytics Market - Industry analysis, size, share, growth, trends, and forecast, 2021-2031.

The application of analytics has appeared as a helpful tool for several biotechnological, pharmaceutical, and medical device enterprises. These options help to enhance operational efficiency and overcome the challenges in data integration. The significant analytics applications in life sciences and pharmaceuticals include marketing/sales support, regulatory compliance reporting, and product/service enablement. The growing prevalence of chronic disease, rising demand for improved data standardization, and technological advancements are the prime factors driving the market during the forecast period. Besides, the rising adoption of analytics for sales and marketing applications and clinical trials has further developed the demand of the life science analytics market during the forecast period.

Click full report at https://www.sheeranalyticsandinsights.com/market-report-research/life-science-analytics-market-21

In recent years, drug organizations are progressively considering digitization as an essential part of system restructuring. With advanced innovations, like versatility and unavoidable figuring, big data, and analytics, organizations can successfully improve their R&D profitability, producing capacities, deals and advertising viability, and consistency with the executives. In assembling measures, examination advancements are being coordinated to catch unit activities information consequently, and in R&D, various labs are going paperless. This methodology has decreased cycle times and limited blunders.

Significant expenses make these arrangements more expensive for little and medium-sized pharma and biotech organizations and CROs with restricted spending plans, in this manner restricting their reception. This pattern is pronounced in arising economies, where it is consistently a battle to get spending plans for IT over clinical hardware.

In need and on-time medication includes utilizing genomic information of a person to create customized medication at ease. With the help of life science analytics, progressed examination, and prescient demonstrating applications can empower associations to treat every tolerant in a customized approach to deliver the ideal results. The investigation has progressively been utilized throughout the long term to create customized medication for cancer and diabetes. According to WHO, more than 156 million patients are harmed due to doctor errors in diagnosing the right disease, and around 4.1 million deaths are observed per year.

The COVID-19 pandemic had attracted many patients visiting medical services centers daily. During Covid, a significant deficiency of hospital beds, medical services suppliers, and essential clinical hardware and management information system (MIS) management of present resources have raised a demand for life science analytics growth. Due to COVID-19 flared-up, the number of teleconsultations and online consultations had expanded at a much faster rate. The reconciliation of electronic health records (EHR) with other medical care IT arrangements, for example, telemedicine and e-recommending functionalities, helps medical services suppliers make an affiliated organization that guarantees the utilization of HC IT systems to analyze and endorse drugs for patients.

Therefore, post-Covid impact, lack of medical care suppliers and supplies, and the requirement for better tolerant information, and the demand for advanced integrated healthcare faciliatory are expected to rely upon Life Science Analytics through the forecast period.The report covers a detailed outlook about the company, and it includes the company or industry profiles and market share of key players operating in the global market. Key players in the report include 3DHISTECH, Accenture, Allscripts Healthcare Solutions, Cerner Corporation, Cerner Corporation, Cognizant, Datavant Inc., IBM, IQVIA, Oracle Corporation, SAS Institute Inc., Scio Health Analytics, Sema4, Microsoft, Take Solutions, TCS, and Wipro Ltd.

Request a Sample Copy of Report: https://www.sheeranalyticsandinsights.com/request-sample/life-science-analytics-market-21

The Global Life Science Analytics Market Has Been Segmented into:

Global Life Science Analytics Market: By Analytics Type

  • Reporting
  • Descriptive
  • Predictive
  • Prescriptive

Global Life Science Analytics Market: By Component

  • Software
  • Services

Global Life Science Analytics Market: By Application

  • Research and Development
  • Sales and Marketing
  • Regulatory Compliance
  • Supply Chain Analytics
  • Pharmacovigilance

Global Life Science Analytics Market: By Delivery

  • On-demand
  • On-premises

Global Life Science Analytics Market: By End-Use

  • Medical Devices
  • Pharmaceutical
  • Biotechnology
  • Others

Global Life Science Analytics Market: By Region

  • North America
    • USA
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, Middle East & Africa
    • Brazil
    • South Africa
    • UAE
    • Rest of LAMEA


About Us     

Sheer Analytics and Insights Private Limited is market research, consulting, and IT services company. We as a company believe in providing point to point data and its analysis with the combination of our human and automation integration. Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, and electronics, materials, consumer goods, defense, and BFSI sector.

Sheer Analytics believes in quality work and ensures that the product delivered to the client is meaningful for them. We publish reports based on our advanced analytics reports, which are generated with the help of our in-house databases, external databases, and artificial intelligence integration processes. We stand out from other market research companies in terms of integrating facts with meaningful insights for forecasting.

Apart from publishing syndicated reports (mostly client reports), we are dealing with projects primarily based on “Go to Market Strategy, Data Mining and Extraction,” meaning full data analysis based on big data and many other database services and content related services.

Our products include quick turnaround datasets, TAM/PAM Analysis to full-fledged deep dive research on top trending markets.



Abhigyan Sengupta

Sheer Analytics and Insights

Email: query@sheeranalyticsandinsights.com


Website: https://www.sheeranalyticsandinsights.com/

Registered Office
RDB Boulevard, 8th Floor, Plot K 1, Sector 5, Block EP and GP, Kolkata 700091, India.
Contact Us
Stay Informed
Submit Your Query
Hot Links